장관 베체트병 환자에서 Thalidomide의 치료 효과
The Effect of Thalidomide on Entero-Behcet's Disease
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Behcet's disease is a chronic relapsing vasculitis characterized by recurrent aphthous oral and genital ulcers with uveitis. Multiple organs can be involved. Entero-Behcet's disease is often uncontrollable, relapsing, and can cause acute intestinal bleeding, fistula formation, or perforation. Corticosteroids, immunosuppressors, and colchicines are used to treat Entero-Behcet's disease with varying degree of success. Thalidomide may also be feasible. We present a 29-year-old male Entero-Behcet's patient suffering from abdominal pain, diarrhea, and back pain. He did not respond to prior treatments, but responded to thalidomide.
Abstract
Behcet's disease is a chronic relapsing vasculitis characterized by recurrent aphthous oral and genital ulcers with uveitis. Multiple organs can be involved. Entero-Behcet's disease is often uncontrollable, relapsing, and can cause acute intestinal bleeding, fistula formation, or perforation. Corticosteroids, immunosuppressors, and colchicines are used to treat Entero-Behcet's disease with varying degree of success. Thalidomide may also be feasible. We present a 29-year-old male Entero-Behcet's patient suffering from abdominal pain, diarrhea, and back pain. He did not respond to prior treatments, but responded to thalidomide.
참고문헌 (18)
- Sakane T, "Behcet's disease", N Engl J Med, 341, pp.1284~1291 (1999)
- Dilsen N, "History and development of Behcet's disease", Rev Rhum Engl Ed, 63, pp.512~519 (1996)
- Yoshikawa K, "Close association of Streptococcus sanguis and Behcet's disease", Nippon Ganka Gakkai Zasshi, 95, pp.1261~1267 (1991)
- Eglin RP, "Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers", Lancet, 2, pp.1356~1361 (1982)
- Chang HK, "HLA-B51 and its allelic types in association with Behcet's disease and recurrent aphthous stomatitis in Korea", Clin Exp Rheumatol, 19, pp.31~35 (2001)
- Kasahara Y, "Intestinal involvement in Behcet's disease: review of 136 surgical cases in the Japanese literature", Dis Colon Rectum, 24, pp.103~106 (1981)
- Whitehead R, "Gastrointestinal and esophageal pathology. 2nd ed", pp.687~709 (1995), Churchill Livingstone
- Kotter I, "Therapy of Behcet's disease", Ger J Ophthalmol, 5, pp.92~97 (1996)
- Pacor ML, "Cyclosporin in Behcet's disease: results in 16 patients after 24 months of therapy", Clin Rheumatol, 13, pp.224~227 (1994)
- Sheskin J, "Thalidomide in the treatment of lepra reactions", Clin Pharmacol Ther, 6, pp.303~306 (1965)
- Saylan T, "Thalidomide in the treatment of Behcet's syndrome", Arch Dermatol, 118, pp.536~536 (1982)
- Hamza MH, "Treatment of Behcet's disease with thalidomide", Clin Rheumatol, 5, pp.365~371 (1986)
- Moreira AL, "Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation", J Exp Med, 177, pp.1675~1680 (1993)
- Suzuki Kurokawa M, "Behcet's disease", Clin Exp Med, 4, pp.10~20 (2004)
- Houman MH, "Promising new therapies for Behcet's disease", Eur J Intern Med, 17, pp.163~169 (2006)
- 장현규, "베체트병의 치료", 대한류마티스학회지, 10(2), pp.1~110 (2003), 대한류마티스학회
- Larsson H, "Treatment of severe colitis in Behcet's syndrome with thalidomide (CG-217)", J Intern Med, 228, pp.405~407 (1990)
- Lee CK, "Pathogenesis and Treatment of Intestinal Behcet's disease", Korean J Gastroenterol, 50, pp.3~8 (2007)